Interestingly, OGDH, OGDHL, and DHTKD1 each possess a ThDP binding domain, and thiamine (vitamin B1) administration is an intriguing treatment possibility, as oral thiamine has been used to improve various neurological disorders with minimal adverse reactions [73–76]. The gene discussed is DHTKD1; the disease is nervous system disorder.